Quality assurance of dosimetry and the impact on sample size in randomized clinical trials

Radiotherapy and Oncology

Volumn 86, Issue 2, 2008, Pages 195-199

  Pettersen, Morten N ^a   Aird, Edwin ^c   Olsen, Dag R ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Dosimetry; Quality assurance; Randomized clinical trial

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE CALCULATION; DOSE RESPONSE; DOSIMETRY; HUMAN; OUTCOME ASSESSMENT; POPULATION SIZE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RISK ASSESSMENT; SAMPLE SIZE;

DOSE-RESPONSE RELATIONSHIP, RADIATION; EVIDENCE-BASED MEDICINE; HUMANS; QUALITY ASSURANCE, HEALTH CARE; RADIOMETRY; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE;

EID: 38949151587     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.07.001     Document Type: Article

References (14)

1. Bentzen S.M. Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol 46 (1998) 5-18
2. Jones B., and Dale R. Radiobiological modeling and clinical trials. Int J Radiat Oncol Biol Phys 48 (2000) 259-265
3. Sydes M.R., Stephens R.J., Moore A.R., et al. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer. Radiother Oncol 72 (2004) 199-211
4. Bentzen S.M. Radiobiological considerations in the design of clinical trials. Radiother Oncol 32 (1994) 1-11
5. Venables K., Miles E.A., Aird E.G., et al., START Trial Management Group. The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial. Radiother Oncol 7 (2004) 303-310
6. Horwich A., Dearnaley D., Huddart R., et al. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer. Radiother Oncol 75 (2005) 34-43
7. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 75 (2005) 9-17
8. Bentzen S.M., and Overgaard J. Clinical normal-tissue radiobiology. In: Tobias J.S., and Thomas P.R.M. (Eds). Current Radiotherapy Oncology (1996), Arnol, London 37-67
9. Wittes J. Sample size calculations for randomized controlled trials. Epidemiol Rev 24 (2002) 39-53
10. Meijer G.J., Minken A.W., and van Ingen K.M. Accurate in vivo dosimetry of a randomized trial of prostate cancer irradiation. Int J Radiat Oncol Biol Phys 49 (2001) 1409-1418
11. Voordeckers M., et al. The implementation of in vivo dosimetry in a small radiotherapy department. Radiother Oncol 47 (1998) 45-48
12. Roue A., Van Dam J., Dutreix A., and Svensson H. The EQUAL-ESTRO external quality control laboratory in France. Cancer Radiother 1 (2004) 44-49
13. Suit H., Skates S., Taghian A., Okunieff P., and Efird J.T. Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother Oncol 25 (1992) 251-260
14. Bentzen S.M. Steepness of the radiation dose-response curve for dose-per-fraction escalation keeping the number of fraction size fixed. Acta Oncol 44 (2005) 825-828